Description of the Neurovisual and Radiological Specificities of Patients With Visual Snow Syndrome (NCT05229731) | Clinical Trial Compass
WithdrawnNot Applicable
Description of the Neurovisual and Radiological Specificities of Patients With Visual Snow Syndrome
Stopped: The investigators no longer want to do the project
France0Started 2022-04-13
Plain-language summary
NEVICOG is a single-center study evaluating neurovisual and radiological specificities in patients with visual snow syndrome (VSS) compared to a control population.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Case group:
* Patient aged up to 55
* Diagnosis of visual snow syndrome according to the international criteria
* Visual snow symptoms still present
* Express consent to participate in the study
Control group:
* Person aged up to 60
* Matched to an SNV patient on age (+/- 5 years) and sex
* Express consent to participate in the study
Exclusion Criteria:
Case group:
* Patient with an absolute or relative contraindication to MRI (claustrophobia, incompatible implantable device, etc.)
* Patient benefiting from a legal protection measure
* Pregnant or breastfeeding woman
* Non-French speaking patient
* Added psychiatric or neurodegenerative pathology unrelated to visual snow likely to induce neurocognitive and neurovisual disorders in the short or long term
* Ophthalmologic comorbidity that may interfere with the interpretation of examinations
Control group:
* Patient with an absolute or relative contraindication to MRI (claustrophobia, incompatible implantable device, etc.)
* Person benefiting from a legal protection measure
* Pregnant or breastfeeding woman
* Non-French speaking person
* Psychiatric or neurodegenerative pathology likely to induce neurocognitive and neurovisual disorders in the short or long term
* Ophthalmologic comorbidity that may interfere with the interpretation of examinations
What they're measuring
1
Results of the neurovisual assessment
Timeframe: 1 day (Inclusion)
Trial details
NCT IDNCT05229731
SponsorFondation Ophtalmologique Adolphe de Rothschild